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Telomeres, the physical ends of eukaryotic chromosomes,
consist of tandem arrays of short DNA repeats and a large
set of specialized proteins. A recent analysis has identiﬁed
telomeric repeat-containing RNA (TERRA), a large non-
coding RNA in animals and fungi, which forms an integral
component of telomeric heterochromatin. TERRA tran-
scription occurs at most or all chromosome ends and it
is regulated by RNA surveillance factors and in response to
changes in telomere length. TERRA functions that are
emerging suggest important roles in the regulation of
telomerase and in orchestrating chromatin remodelling
throughout development and cellular differentiation. The
accumulation of TERRA at telomeres can also interfere
with telomere replication, leading to a sudden loss of
telomere tracts. Such a phenotype can be observed upon
impairment of the RNA surveillance machinery or in cells
from ICF (Immunodeﬁciency, Centromeric region instabil-
ity, Facial anomalies) patients, in which TERRA is upre-
gulated because of DNA methylation defects in the
subtelomeric region. Thus, TERRA may mediate several
crucial functions at the telomeres, a region of the genome
that had been considered to be transcriptionally silent.
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Introduction
Telomeres are critical at the cellular level for genome stability,
whereas at the organismal level, they act as tumour suppres-
sors and may contribute to ageing. The following roles of
telomeres are well established: First, telomeres can regulate
the lifespan of cells (Harley et al, 1990; Allsopp et al, 1992;
Levy et al, 1992; Bodnar et al, 1998). Telomere shortening
occurs at the distal ends because of a combination of nucleo-
lytic processing of chromosome ends and the end replication
problem. This shortening can be counteracted by the cellular
reverse-transcriptase telomerase, which uses an internal RNA
moiety as a template for the synthesis of telomere repeats
(Cech, 2004; Blackburn et al, 2006). Telomerase is regulated
at individual chromosome ends through telomere-binding
proteins to mediate telomere length homoeostasis; however,
in humans, telomerase is expressed in most tissues only
during the ﬁrst weeks of embryogenesis (Ulaner and
Giudice, 1997). Repression of telomerase in somatic cells is
thought to result in a powerful tumour-suppressive function.
Short telomeres that accumulate following an excessive
number of cell division cycles induce cellular senescence,
and this counteracts the growth of pre-malignant lesions.
This growth barrier is overcome in most cancers that contain
cells that re-express telomerase. Second, telomeres protect
natural chromosome ends from unwanted DNA repair activ-
ities, which include non-homologous end joining and homo-
logous recombination (Palm and de Lange, 2008). Several
telomere-associated proteins are critical for this function.
Third, telomeres establish a heterochromatic state at chromo-
some ends, which is characterized by the presence of tri-
methylated lysines at position 9 in histone H3 and at position
20 in histone H4, histone hypoacetylation, the accumulation
of several isoforms of heterochromatin protein 1 and the
hypermethylation of cytosines in CpG dinucleotides that are
present in subtelomeric regions (Blasco, 2007; Ottaviani et al,
2008). The heterochromatic state of telomeres may contribute
to chromosome positioning and movement within the nu-
cleus and also to the regulation of telomerase. Abnormal
telomeric chromatin states have been linked to severe
stochastic telomere sequence loss phenotypes, suggesting
crucial roles of this structure during telomere replication
(Michishita et al, 2008; Yehezkel et al, 2008).
Several telomere-binding proteins that are crucial for the
distinct telomere functions outlined above have been identi-
ﬁed. These include the six-polypeptide-containing shelterin
complex (Palm and de Lange, 2008), which is abundant at
telomeres as well as other more rare telomeric proteins.
However, relatively little is known mechanistically about
which telomere transitions occur between different states
for example: when to activate telomerase in a length-depen-
dent and cell-cycle-restricted manner; when to induce cellular
senescence when telomeres are very short; and when to lose
protection from end fusion upon further erosion. Recent
analysis has identiﬁed telomeric repeat-containing RNA
(TERRA), a large non-coding RNA in animals and fungi,
which forms an integral component of telomeric heterochro-
matin (Azzalin et al, 2007; Luke et al, 2008; Schoeftner and
Blasco, 2008). Earlier reports also indicate the existence of
telomere transcription in trypanosomes, birds and Diptera
Received: 27 April 2009; accepted: 25 May 2009; published online:
23 July 2009
*Corresponding author. EPFL, School of Life Sciences-ISREC, Ba ˆtiment
SV, Station 19, Lausanne 1015, Switzerland.
Tel.: þ41 21 693 0721; Fax: þ41 21 693 0720;
E-mail: joachim.lingner@epﬂ.ch
The EMBO Journal (2009) 28, 2503–2510 | & 2009 European Molecular Biology Organization|Some Rights Reserved 0261-4189/09
www.embojournal.org
&2009 European Molecular Biology Organization The EMBO Journal VOL 28 | NO 17 | 2009
 
EMBO
 
THE
EMBO
JOURNAL
THE
EMBO
JOURNAL
2503(Morcillo et al, 1988; Rudenko and Van der Ploeg, 1989;
Solovei et al, 1994). The ﬁnding of ribonucleic acids at
telomeres adds a new dimension of how functions at the
telomere may be orchestrated and regulated. Here, we review
recent progress in the understanding of TERRA biogenesis,
turnover and function.
TERRA biogenesis
TERRA is a heterogeneous non-coding RNA that consists of a
combination of subtelomeric and telomeric sequences. To date,
all individual telomeres tested in mammals can and do produce
TERRA transcripts and TERRA is expressed in most tissues
(Azzalin et al, 2007; Azzalin and Lingner, 2008; Schoeftner and
Blasco, 2008). TERRA is transcribed in a centromere to telo-
mere direction, indicating that the transcription start site lies
within the subtelomeric sequence. In the yeast, Saccharomyces
cerevisiae, it has been determined that TERRA transcription
occurs at both, telomeres containing or lacking the Y0 element.
The Y0 element is a conserved repeat sequence, present at
B50% of all telomeres in S. cerevisiae.T h e5 0-end of TERRA
derived from telomeres containing the Y0 element is relatively
homogenous, supporting the idea of a deﬁned start site (Luke
et al, 2008). This suggests that the heterogeneity of TERRA
stems from its 30-end, and indicates either that transcription
can terminate in multiple places within the telomeric tract, or
that TERRA 30-ends are differentially processed. TERRA is
transcribed largely by RNA polymerase II (RNAPII). This
conclusion was reached because of the fact that RNAPII was
found associated with telomeric DNA through chromatin
immunoprecipitation (ChIP) experiments in human, mouse
and yeast cells (Luke et al, 2008; Schoeftner and Blasco,
2008). Furthermore, the speciﬁc inhibition of RNAPII by
a-amanitin reduces the abundance of TERRA in both human
and mouse cells (Schoeftner and Blasco, 2008). Moreover,
a temperature-sensitive RNAPII allele (rpb3-2) prevents the
accumulation of TERRA in budding yeast (Luke et al, 2008).
Although a-amanitin does reduce, to a large extent, the abun-
dance of TERRA in mammalian cells, it is far less efﬁcient in
doing so than the general transcriptional inhibitor, actinomycin
D. Where actinomycin D treatment resulted in a 50% reduction
in TERRA levels within 2.5–3h (Azzalin et al, 2007; Schoeftner
and Blasco, 2008), only B30% of TERRA was degraded after
6hofa-amanitin treatment, and 20% of initial TERRAwas still
remaining after 12h of treatment (Schoeftner and Blasco,
2008). Similar results were seen in mouse cells treated with
a-amanitin, in which TERRA levels never decreased below
50% of initial levels even after 12h of RNAPII inhibition
(Schoeftner and Blasco, 2008). These results indicate that
although RNAPII has a major function in promoting TERRA
transcription, there may be another RNA polymerase (either
RNAPI and RNAPIII) that could potentially have a function in
telomeric transcription in mammals. The idea of another RNA
polymerase being involved in generation of TERRA would be
consistent with recent data in which several subunits of RNAPI
and RNAPIII (RPABC1, RPAC1, RPA49, RPA2 and RPA1) were
found enriched in formaldehyde-crosslinked and partially pur-
iﬁed human telomere fractions (Dejardin and Kingston, 2009).
Furthermore in trypanosomatida, telomeres can be transcribed
both by RNAPII and, in the subset of trypanosomes that show
antigenic variation, by the a-amanitin-resistant RNAPI
(Rudenko and Van der Ploeg, 1989).
Similar to most products of RNAPII transcription, TERRA
is polyadenylated at its 30-end (Azzalin and Lingner,
2008; Luke et al, 2008; Schoeftner and Blasco, 2008).
Approximately 7% of human TERRA is polyadenylated
(Azzalin and Lingner, 2008), whereas most or all yeast
TERRA molecules carry a poly(A) tail (Luke et al, 2008). It
is unknown whether TERRA polyadenylation involves the
30-end cleavage of a longer TERRA precursor or whether
terminated transcripts are directly polyadenylated. A canoni-
cal 50-AAUAAA-30 cleavage and a polyadenylation signal is
not present at mammalian TERRA 30-ends, whereas the
telomere-derived GU-rich TERRA 30-ends in yeast bear some
resemblance to the canonical U-rich 30-end-processing signals
in this organism. In yeast, the canonical polyadenylation
polymerase, Pap1, is responsible for poly(A) addition and it
most likely contributes to the stability of the RNA, because
TERRA becomes completely destabilized in pap1-1 tempera-
ture-sensitive mutants and polyadenylated TERRA is no long-
er detectable (Luke et al, 2008). How the 50-end of TERRA is
modiﬁed has not yet been addressed. If it contains a
7-methylguanosine (m
7G) cap structure as do mRNAs, it likely
gets uncapped in S. cerevisiae at the time when it becomes
a target for Rat1-dependent degradation, which recognizes
50-uncapped mono-phosphate structures (see below).
Although the speciﬁc transcription factors that are respon-
sible for the transcriptional regulation of TERRA have not yet
been elucidated, there are indications that some of the telo-
mere-bound proteins that make up the protective cap of
telomeres, along with the heterochomatic markers present at
telomeres, are involved in controlling TERRA levels. As dis-
cussed in the Introduction section, telomeres are often in a
heterochromatic state (Blasco, 2007; Ottaviani et al, 2008).
Trichostatin A, a histone deacetylase inhibitor, results in in-
creased TERRA levels in human cells (Azzalin and Lingner,
2008) as do mutations in the histone methyltransferases,
SUV39H1/2 and SUV4-20H1/2, in mouse cells (Schoeftner
and Blasco, 2008) and mutations in the DNA methyltransferase
3b (DNMT3B) in human cells (Yehezkel et al,2 0 0 8 ) .T h e s e
results indicate that TERRA levels are partially controlled
through subtle changes in the local heterochromatin, although
indirect effects could not be distinguished in these experiments.
Shelterin is a complex composed of six proteins (TRF1,
TRF2, Rap1, TIN2, TPP1 and POT1), which binds to and
protects telomeres (Palm and de Lange, 2008). Interestingly,
TRF1 can interact with RNAPII as shown through co-immu-
noprecipitation experiments (Schoeftner and Blasco, 2008). It
has been reported that when TRF1 was depleted using small-
interfering RNA (siRNA), overall levels of TERRA decreased
twofold, which suggests that TRF1 supports TERRA tran-
scription (Schoeftner and Blasco, 2008). It is unlikely, how-
ever, that TRF1 acts as a conventional transcriptional
activator. First, depletion of TRF1 does not result in a
corresponding loss of RNAPII associated with telomeric
DNA. Second, TRF1 is restricted to the telomeric tract and
likely does not spread into the subtelomere, wherein tran-
scription is presumed to initiate. Finally, the overproduction
of TRF1 results in less TERRA production, rather than more,
although it should be noted that telomeres shorten in length
upon TRF1 overexpression and this may also inﬂuence
TERRA transcription (Benetti et al, 2008; Schoeftner and
Blasco, 2008; Munoz et al, 2009). Overall, these data suggest
that TRF1 promotes RNAPII progression through the telo-
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ment (see Figure 1, TERRA transcription).
It is important to re-visit all of the known telomere-
associated proteins (shelterin and non-shelterin components)
and re-assess their functions in terms of TERRA regulation.
This also includes several proteins that could be potentially
involved in transcription elongation and regulation, which
were detected in partially puriﬁed telomere fractions
(Dejardin and Kingston, 2009).
TERRA at telomeres
TERRA is exclusively found in nuclear RNA fractions from
human and mouse cells, and is likely restricted to the nucleus
in yeast as well (see below). Furthermore, TERRA can be
detected using RNA ﬂuorescence in situ hybridization (RNA-
FISH) at a subset of telomeres in interphase cells, and it is
present on human and mouse chromosome ends in the
metaphase of the cell cycle (Azzalin et al, 2007; Schoeftner
and Blasco, 2008). The fact that TERRA associates with
telomeres suggests that TERRA may be an integral part of
the telomere and could potentially be important for structural
integrity. However, because TERRA is detected by FISH in
only a subset of telomeres, it seems more likely that TERRA is
not an essential or a permanent constituent of the telomeric
chromatin, but rather has a transient structural function
during telomere assembly or it may have regulatory roles in
a subset of telomeres that may correspond to a speciﬁc
functional state. A telomere autonomous regulation would
be compatible with telomeric-state-dependent functions; for
example, in the establishment, but not necessarily the main-
tenance, of telomeric heterochromatin or in the regulation of
telomerase in cis in a length-dependent manner. Although
TERRA remains associated with telomeres, it has not been
shown whether TERRA molecules can move from one telo-
mere to another or whether the RNA remains associated with
the telomere that it was transcribed from.
There are two potential means by which TERRA could be
tethered to telomeres. One possibility would be through
interactions of a telomeric protein with the RNA or, alterna-
tively, through a direct interaction of TERRA with the telo-
meric DNA. Both modes of association are possible and are
indeed not mutually exclusive. In yeast, mainly indirect
evidence has hinted that DNA–RNA hybrid formation is
occurring to some extent. It was shown that overexpression
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Figure 1 TERRA Biogenesis, telomere association and displacement from telomeres. TERRA Biogenesis (upper panel)—TERRA is an RNAPII-
dependent transcript whose transcription initiates within the subtelomeric sequences and proceeds into the telomeric tract. Human TRF1 may
promote transcription through the telomere tract through its association with RNAPII. A fraction of TERRA is polyadenylated through the
canonical poly(A) polymerase, Pap1. The 50-end structure that exists on TERRA molecules has not yet been reported. Telomere association
(middle panel)—TERRA colocalizes with telomeres as visualized by RNA-FISH experiments on human interphase and metaphase chromo-
somes. Indirect evidence suggests that at least a portion of TERRA is bound to telomeres through base pairing with telomeric DNA. Undeﬁned
RNA–protein interactions or intermolecular G-quadruplex structures (Gquad) may also tether TERRA to telomeric DNA. Telomere removal and
degradation (lower panel)—the 50 to 30 exonuclease, Rat1, directly degrades TERRA molecules and can itself be found associated with
telomeres. Rat1 can degrade its other target RNAs in a co-transcriptional manner (as depicted here), whether TERRA is degraded by Rat1 in a
similar manner has yet to be determined. The poly(A) polymerase, Trf4, also contributes to TERRA degradation, although likely as a minor
contributor compared with Rat1. The NMD factors, UPF1, SMG1 and EST1A/SMG6, all contribute to TERRA removal from telomeres.
Inhibition of any of these factors results in both more and brighter TERRA foci, although overall TERRA levels as assessed by northern blot
analysis remain largely unchanged. RNaseH overexpression also reduces cellular TERRA levels when Rat1 function is impaired.
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hybrid, could speciﬁcally reduce TERRA levels in a genetic
background in which TERRA accumulates (Luke et al, 2008).
Furthermore, it was shown in vitro that telomeric DNA and
telomeric RNA together form an intermolecular heat-stable
G-quadruplex structure (Xu et al, 2008). To date, there is no
evidence that telomeric proteins are involved in the tethering
of TERRA to chromosome ends. POT1, a good candidate that
binds to telomeric ssDNA in mammals, does not interact with
TERRA in vitro (S Redon and JL, unpublished data). Another
candidate in mammalian cells is hnRNP A1, an abundant
RNA-binding protein that binds speciﬁcally to UAGGGA/U
repeats in vitro (Burd and Dreyfuss, 1994). UUAGGG repeats
are very abundant in the portion of mammalian TERRA that
is transcribed from telomeric repeats. hnRNP A1 has also
been implicated in telomere length control (LaBranche et al,
1998) and it binds to single-stranded telomeric repeats in
vitro (McKay and Cooke, 1992) and to telomeres in vivo
(Zhang et al, 2006). Thus, it might function as a molecular
bridge between telomeric DNA and TERRA. Telomere puriﬁ-
cation also showed other RNA-binding proteins, including
FUS, RNA-binding protein 14, cold-induced RNA-binding
protein and RNA-binding protein 8A (Dejardin and
Kingston, 2009), all of which might be involved in TERRA
localization to telomeres (Figure 1, see TERRA telomere
association).
TERRA regulators
Several negative regulators of both TERRA stability and
TERRA localization have now been documented. The non-
sense-mediated RNA decay (NMD) machinery, which is best
known for its role in the degradation of mRNAs containing
pre-mature termination codons, has also an important func-
tion in the displacement of TERRA from human telomeres
(Azzalin et al, 2007; Chawla and Azzalin, 2008). From the
key players in the NMD pathway, UPF1, SMG1 and EST1A/
SMG6 were shown to regulate TERRA at telomeres, as their
depletion by RNA interference (RNAi) led to a several-fold
increase of telomeres with TERRA foci. However, neither total
levels of TERRA nor TERRA half-life was affected by the
depletion of these factors. NMD proteins may interact directly
with TERRA at telomeres because NMD proteins can be
detected at telomeres in vivo by ChIP (Azzalin et al, 2007).
Furthermore, the NMD factor, EST1A/SMG6, physically inter-
acts with telomerase (Reichenbach et al, 2003; Snow et al,
2003; Redon et al, 2007). Two possible scenarios on how
NMD factors diminish TERRA abundance at telomeres can be
envisioned. First, UPF1/SMG1/EST1A may be required only
for the displacement of TERRAwithout inﬂuencing the rate of
TERRA degradation. Second, UPF1/SMG1/EST1A may be
involved in TERRA degradation, but only locally at the
telomere, and such small changes in TERRA levels are not
discernable on northern blots. In this respect, it is interesting
to note that EST1A/SMG6 contains a PIN domain at its
C terminus, which shows RNA endonuclease activity
during NMD (Huntzinger et al, 2008; Eberle et al, 2009).
Distinguishing between these two possibilities will be tech-
nically challenging.
It is not known whether yeast TERRA resides at the
telomere as is the case in complex eukaryotes; therefore,
regulators of TERRA localization have not yet been addressed
in this organism. However, it is intriguing that inactivation of
the NMD machinery in S. cerevisiae leads to shorter telo-
meres, although it had been proposed that this effect was due
to increased expression levels of the telomere-capping fac-
tors, Stn1 and Ten1, which were observed in NMD mutants
(Dahlseid et al, 2003; Enomoto et al, 2004). In yeast,
NMD mutants did not affect overall TERRA levels (Luke
et al, 2008), but similar to human cells, they might only
locally affect TERRA, rendering the effect undetectable on
northern blots.
It has been determined, however, that the stability of
TERRA in yeast is tightly regulated by the 50-t o3 0-exonu-
clease, Rat1. In wild-type cells, TERRA is almost undetectable
using standard northern blotting procedures, but accumu-
lates signiﬁcantly when Rat1 is inactive. These effects are
likely to be direct. Mutation in the RAT1 gene increases the
half-life of TERRA; moreover, Rat1 can be found to be
associated with telomeres through ChIP experiments. On
the other hand, Xrn1, the cytoplasmic paralog of Rat1, has
no effect on TERRA levels, supporting the notion that, similar
to its human counterpart, yeast TERRA is nuclear. Trf4, an
alternative poly(A) polymerase that is often associated with
exosomal-mediated degradation, has no effect on TERRA
levels when mutated singly; however; when combined with
a Rat1 mutation, the double-mutant shows a dramatic in-
crease in TERRA levels. This suggests that Trf4 has a minor
function in TERRA degradation on its own; however, when
Rat1 is mutated and TERRA levels are higher, the contribu-
tion of Trf4 becomes more noticeable. In this respect, analysis
of double mutants (with one mutation being the rat1-1
mutation) may be instrumental in ﬁnding additional regula-
tors of TERRA stability and, furthermore, of TERRA trans-
criptional activation (Figure 1, see TERRA removal and
degradation).
TERRA function
Telomerase
As discussed above, in human cells, TERRA is displaced or
degraded at telomeres by NMD factors that physically interact
with telomeric chromatin (Azzalin et al, 2007). Among these
factors, EST1A/SMG6 was also identiﬁed through its se-
quence similarity with the S. cerevisiae telomerase-associated
protein, Est1 (Reichenbach et al, 2003; Snow et al, 2003).
Moreover, similar to yeast Est1, human EST1A/SMG6 physi-
cally interacts with telomerase (Reichenbach et al, 2003;
Snow et al, 2003; Redon et al, 2007). The S. cerevisiae Est1
protein binds directly to telomerase RNA and to the single-
stranded telomeric DNA-binding protein, Cdc13p, to recruit
telomerase to chromosome ends in the S phase. Therefore, in
est1D cells, telomerase cannot act and telomeres shorten
(Lundblad and Szostak, 1989; Pennock et al, 2001; Chan
et al, 2008). The recruitment and activation of telomerase
at chromosome ends is not well understood in complex
eukaryotes, including humans, and the role of EST1A/
SMG6 in this process is uncertain. The association of
EST1A/SMG6 with telomerase is compatible with a role in
telomerase regulation, but its effects on TERRA displacement
at telomeres suggest that EST1A/SMG6 may regulate telo-
merase through TERRA. Indeed, the TERRA-mimicking
RNA oligonucleotide (UUAGGG)3 inhibits telomerase activity
in vitro as determined in the TRAP assay (Schoeftner and
TERRA and telomeres
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telomeres are long (Azzalin et al, 2007; Schoeftner and
Blasco, 2008), it has been proposed that telomerase may be
regulated by TERRA in a telomere-length-dependent manner
(Schoeftner and Blasco, 2008). Consistent with a negative
regulatory role of TERRA for telomerase is also the ﬁnding
that in several tumours, lower levels of TERRA were detec-
ted than in the corresponding normal tissue (Schoeftner
and Blasco, 2008). Furthermore, in tumour-derived and in
in vitro-immortalized cell lines, the presence of telomerase
activity correlates with lower TERRA levels when compared
with cell lines that use the recombination-based ALT pathway
to maintain telomeric ends (Ng et al, 2009). Genetic experi-
ments in S. cerevisiae provide more conclusive evidence that
TERRA indeed regulates telomerase in vivo. In the rat1-1
mutant background, TERRA is upregulated and telomeres are
shorter than in wild-type cells because of an impairment in
telomerase-mediated telomere elongation (Luke et al, 2008).
The overexpression of RNaseH reduced TERRA levels and
could overcome the short telomere phenotype, indicating that
a DNA/TERRA hybrid was responsible for the effect. Further
support for the role of TERRA in inhibiting telomerase in vivo
stems from an observation that forced telomere transcription
(through the use of a strong Gal promoter) leads to telomere
shortening of the transcribed telomere in cis (Sandell et al,
1994). It will be interesting to elucidate the mode of inhibi-
tion of the enzymatic activity of telomerase by TERRA and to
determine its possible effects on the recruitment of telomer-
ase to telomeres.
Heterochromatin
Large ncRNAs can mediate epigenetic changes by recruiting
chromatin-remodelling complexes to speciﬁc genomic loci.
For example, in the human HOXD locus, the 2.2-kb HOTAIR
ncRNA interacts with the polycomb repressive complex 2,
resulting in trimethylated histone H3 at lysine 27 (H3K27)
(Rinn et al, 2007). Similarly, for X chromosome inactivation
of one of the two X chromosomes in females, transcription of
the 1.6-kb RepA RNA within the Xist locus is involved in
recruiting polycomb group proteins for H3K27 trimethylation
(Zhao et al, 2008). Thus, it would not be surprising if TERRA
also functions as a recruiter for chromatin-modifying en-
zymes at telomeres to establish or stabilize the heterochro-
matic state.
More clearly established is another parallel between Xist
and TERRA, in which both are regulated by SMG proteins.
Female mouse embryonic stem (ES) cell lines depleted for
RENT1 (the murine ortholog of UPF1) or for UPF2 fail to form
Xist RNA domains upon differentiation, and subsequently fail
to undergo X-inactivation (Ciaudo et al, 2006). Thus, nuclear
SMG proteins may contribute to chromatin organization at
several loci that involve long ncRNAs. However, methods
that allow a direct manipulation of TERRA transcription or
stability will be required to elucidate this issue. Furthermore,
TERRA has been shown to colocalize with Xist (Schoeftner
and Blasco, 2008; Zhang et al, 2009) and speciﬁcally with the
distal telomere of the inactive X chromosome in female
mouse embryo ﬁbroblasts (Zhang et al, 2009). Curiously,
TERRA localization to the inactive X does not depend on Xist
expression, which also indicates that TERRA is not dependent
on X chromosome inactivation but rather likely plays a
telomere-speciﬁc heterochromatinization role. In the ﬁssion
yeast Schizosaccharomyces pombe, siRNAs are produced from
subtelomeric repetitive elements referred to as dh repeats,
whereby both the RNAi RITS (RNA-induced initiation of
transcriptional silencing) pathway and the major telomere-
binding protein Taz1 (ortholog of human TRF1 and TRF2)
establish Swi6 (ortholog of HP1) heterochromatin at telo-
meres in parallel pathways (Kanoh et al, 2005). Two lines of
evidence suggest a possible function for RNAi in maintaining
the telomeric structure and TERRA regulation in mammals.
First, upon transfection of mouse cells with synthetic siRNAs,
irrespective of the siRNA sequence used, the Argonaute 1
protein associates with telomeres and TERRA expression
increases (Ho et al, 2008). Second, the inactivation of Dicer
had effects on TERRA levels in mouse ES cells in two different
studies, although it needs to be resolved whether levels
increase or decrease, as the reports were conﬂicting on this
issue (Schoeftner and Blasco, 2008; Zhang et al, 2009). It will
be interesting to determine whether TERRA also base pairs
with other cellular RNAs and whether it is directly processed
into small RNA species by Dicer, which cleaves long dsRNA
molecules into short fragments as a ﬁrst step in the RNAi
pathway. Intriguingly, telomeric antisense transcripts, termed
‘ARRET’, have been detected in budding yeast (Houseley
et al, 2007; Luke et al, 2008), although the canonical RNAi
machinery does not exist in this organism.
Development
Recent reports have also shown that TERRA may be regulated
developmentally and, in turn, may be important for orches-
trating some aspects of the complex chromosome transac-
tions that occur during cellular differentiation (Schoeftner
and Blasco, 2008; Marion et al, 2009; Zhang et al, 2009).
Interestingly, in undifferentiated ES cells, TERRA can be
found to be associated with both X chromosomes in females
and with both X and Y chromosomes in males (Zhang et al,
2009). After differentiation, only one sex chromosome is
marked with TERRA (Xi in females and Y in males,), indicat-
ing that TERRA localization is developmentally regulated.
Consistently, when differentiated ﬁbroblasts are induced to
form pluripotent stem cells with the reprogramming factors,
Oct3/4, Sox2, Klf4 and cMyc, TERRA levels are greatly
increased (Marion et al, 2009). It is not yet clear whether
the reprogramming itself is responsible for increased TERRA
levels or whether the reprogramming factors are direct tran-
scriptional regulators of TERRA.
TERRA dysfunction
Replication
Human cells depleted for UPF1, hEST1A and SMG1 increase
the number of TERRA foci at chromosome ends and they lose
entire telomeric tracts at a high rate. UPF1 depletion also
causes severe DNA damage elsewhere in the genome and
ATR-dependent checkpoint activation in the S phase (Azzalin
and Lingner, 2006). The association of NMD factors with
chromatin and their enrichment at telomeres suggest a causal
link between proper TERRA displacement from telomeres and
telomere integrity (Azzalin et al, 2007), and possibly the
removal of other chromatin-associated RNA molecules by
NMD factors elsewhere in the genome. Removal of TERRA
and potentially other RNAs seems to be important for proper
DNA replication and S-phase progression also in S. cerevisiae,
TERRA and telomeres
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mutant cells that upregulate TERRA (Luke et al, 2008).
Replication might be impeded when TERRA hybridizes to
single-stranded telomeric DNA, leading to the arrest of the
replication fork and to the generation of double-stranded
breaks in the telomeric tract (Figure 2). Interestingly,
human UPF1 also physically interacts with DNA polymerase
d (Carastro et al, 2002; Azzalin and Lingner, 2006). Thus, one
could speculate that DNA polymerase d recruits UPF1 in
conjunction with other SMG factors to displace TERRA
from telomeres during progression of the replication fork.
One speculative hypothesis would be that upon fork stalling
and SMG recruitment to the replication fork, telomerase,
through EST1A/SMG6, is also recruited in the event that de
novo telomere addition is required after replication fork
collapse to heal the broken telomere, or simply to ensure
that telomerase is correctly deposited at the chromosome end
in a timely manner (Figure 2). This model, as well as other
models that may explain the observed phenotypes, needs to
be tested in the future.
Several features seen in SMG-depleted cells were recently
also detected in cells derived from ICF (Immunodeﬁciency,
Centromeric region instability, Facial anomalies) patients,
who carry defective genes for DNA methyltransferase 3b
(DNMT3b). DNMT3b defects lead to hypomethylation of
CpG dinucleotides in heterochromatic regions, including
pericentromeric satellites, the inactive X chromosome and
in subtelomeric regions. Intriguingly, ICF patient-derived
cells also harbour short telomeres and display increased
TERRA levels (Yehezkel et al, 2008). Furthermore, many
chromosome ends in ICF patient-derived cells lacked detect-
able telomeric DNA signals altogether. Thus, as in the case of
SMG depletion, TERRA upregulation correlates with a sudden
telomere loss in ICF patient-derived cells.
Perspective
The notion that the ends of our chromosomes are transcribed
into TERRA and that telomeric chromatin contains RNA
molecules adds another fascinating level of complexity and
provides another example of a structural RNA molecule that
may prove to be of utmost importance. TERRA and other
chromatin-associated RNA molecules have the unique feature
that they are synthesized at the site of their action. Thus, their
synthesis rate is closely related to changes in the chromatin
structure. Therefore, TERRA seems ideally suited to initiate
an appropriate response at a telomere in reaction to other
local changes at a telomere, which may involve length
Telomere Subtelomere
UPF1/SMG
TERRA
removal &
replication
Telomerase
TERRA DNA methylation
Replication fork
Replication fork
UPF1
EST1A
Telomere Subtelomere
TERRA
dysfunction
Telomerase
Replication fork collapse
Figure 2 Telomere dysfunction associated with TERRA. TERRA removal upon DNA replication (upper panel): As the replication fork passes
into the subtelomeric and telomeric regions, TERRA may potentially create an obstacle through the formation of an RNA/DNA hybrid. DNA
methylation within the subtelomeric tract is one potential means of ensuring that the levels of the telomeric transcript remain low. hUPF1,
which associates with the replicative polymerase, may encounter such hybrids and be involved in their active displacement through its helicase
activity. EST1A/SMG6 may also be involved in actively removing TERRA molecules, perhaps through its endonuclease activity. Moreover,
EST1A could potentially be involved in the recruitment of telomerase to irreversible fork pausing/collapse events in which rapid de novo
telomere addition is required. TERRA accumulation and telomere dysfuntion (lower panel): In ICF patient cells, levels of DNA methylation in
the subtelomeric regions are greatly reduced because of mutations in the DNA methyltransferase, DNMT3b. These cells consequently express
higher levels of TERRA and may, as a result, experience an increased frequency of replication fork collapse resulting in the observed increase in
telomere loss events. These effects would potentially be augmented in these cells because of the inherent ability of TERRA to inhibit telomerase
activity and therefore to prevent telomere healing at the collapsed fork. These phenotypes are re-capitulated in cells in which SMG protein
function has been experimentally reduced, in that TERRA accumulates at telomeres and cells lose large tracts of telomeric DNA. In this
instance, the combination of TERRA accumulation and lack of SMG proteins may together inhibit telomerase activity and prevent its
recruitment, respectively, to collapsed forks within the telomeric tracts.
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proposed for the centromeric heterochromatin in ﬁssion yeast
that a boost of transcription occurs in the S phase of the cell
cycle in order to trigger assembly of the heterochromatin,
which, when fully assembled, prevents further transcription
at the centromere during other phases of the cell cycle
(Kloc and Martienssen, 2008). Similarly, TERRA may trigger
heterochromatin assembly at the telomere, contribute to the
regulation of telomerase at individual chromosome ends in a
length-dependent manner and, perhaps, even be involved in
DNA damage response at short telomeres.
Several of the above-discussed biological functions of
TERRA are still speculative, and the underlying mechanisms
of action remain to be discovered. The telomeric dysfunctions
of TERRA that can lead to sudden telomere loss are also very
ill deﬁned. Clearly, it is important to analyze the mechanisms
of TERRA biogenesis and turnover, identify the protein
factors that interact and collaborate with TERRA and eluci-
date their mechanisms of action. These studies may also
uncover or show possible functions of TERRA during tumouri-
genesis or animal development. These are exciting times on
planet earth (TERRA)—a feel of change is coming on for our
views on how chromosome ends are regulated and how they
function.
Acknowledgements
Work in JL’s laboratory was supported by grants from the Swiss
National Science Foundation, the Human Frontier Science Program,
the EU 7th Framework Programme and by an ERC-advanced
investigator grant.
References
Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher
AB, Greider CW, Harley CB (1992) Telomere length predicts
replicative capacity of human ﬁbroblasts. Proc Natl Acad Sci
USA 89: 10114–10118
Azzalin CM, Lingner J (2006) The human RNA surveillance factor
UPF1 is required for S phase progression and genome stability.
Curr Biol 16: 433–439
Azzalin CM, Lingner J (2008) Telomeres: the silence is broken. Cell
Cycle 7: 1161–1165
Azzalin CM, Reichenbach P, Khoriauli L, Giulotto E, Lingner J
(2007) Telomeric repeat containing RNA and RNA surveillance
factors at mammalian chromosome ends. Science 318: 798–801
Benetti R, Schoeftner S, Munoz P, Blasco MA (2008) Role of TRF2 in
the assembly of telomeric chromatin. Cell Cycle 7: 3461–3468
Blackburn EH, Greider CW, Szostak JW (2006) Telomeres and
telomerase: the path from maize, Tetrahymena and yeast to
human cancer and aging. Nat Med 12: 1133–1138
Blasco MA (2007) The epigenetic regulation of mammalian telo-
meres. Nat Rev 8: 299–309
Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB,
Harley CB, Shay JW, Lichtsteiner S, Wright WE (1998) Extension
of life-span by introduction of telomerase into normal human
cells. Science 279: 349–352
Burd CG, Dreyfuss G (1994) RNA binding speciﬁcity of hnRNP A1:
signiﬁcance of hnRNPA1 high-afﬁnity binding sites in pre-mRNA
splicing. EMBO J 13: 1197–1204
Carastro LM, Tan CK, Selg M, Jack HM, So AG, Downey KM (2002)
Identiﬁcation of delta helicase as the bovine homolog of HUPF1:
demonstration of an interaction with the third subunit of DNA
polymerase delta. Nucleic Acids Res 30: 2232–2243
Cech TR (2004) Beginning to understand the end of the chromo-
some. Cell 116: 273–279
Chan A, Boule JB, Zakian VA (2008) Two pathways recruit telomerase
to Saccharomyces cerevisiae telomeres. PLoS Genet 4: e1000236
Chawla R, Azzalin CM (2008) The telomeric transcriptome
and SMG proteins at the crossroads. Cytogenet Genome Res 122:
194–201
Ciaudo C, Bourdet A, Cohen-Tannoudji M, Dietz HC, Rougeulle C,
Avner P (2006) Nuclear mRNA degradation pathway(s) are im-
plicated in Xist regulation and X chromosome inactivation. PLoS
Genet 2: e94
Dahlseid JN, Lew-Smith J, Lelivelt MJ, Enomoto S, Ford A,
Desruisseaux M, McClellan M, Lue N, Culbertson MR, Berman
J (2003) mRNAs encoding telomerase components and regulators
are controlled by UPF genes in Saccharomyces cerevisiae.
Eukaryot Cell 2: 134–142
Dejardin J, Kingston RE (2009) Puriﬁcation of proteins associated
with speciﬁc genomic loci. Cell 136: 175–186
Eberle AB, Lykke-Andersen S, Muhlemann O, Jensen TH (2009)
SMG6 promotes endonucleolytic cleavage of nonsense mRNA in
human cells. Nat Struc Mol Biol 16: 49–55
Enomoto S, Glowczewski L, Lew-Smith J, Berman JG (2004)
Telomere cap components inﬂuence the rate of senescence in
telomerase-deﬁcient yeast cells. Mol Cell Biol 24: 837–845
Harley CB, Futcher AB, Greider CW (1990) Telomeres shorten
during ageing of human ﬁbroblasts. Nature 345: 458–460
Ho CY, Murnane JP, Yeung AK, Ng HK, Lo AW (2008) Telomeres
acquire distinct heterochromatin characteristics during siRNA-
induced RNA interference in mouse cells. Curr Biol 18: 183–187
Houseley J, Kotovic K, El Hage A, Tollervey D (2007) Trf4 targets
ncRNAs from telomeric and rDNA spacer regions and functions
in rDNA copy number control. EMBO J 26: 4996–5006
Huntzinger E, Kashima I, Fauser M, Sauliere J, Izaurralde E (2008)
SMG6 is the catalytic endonuclease that cleaves mRNAs contain-
ing nonsense codons in metazoan. RNA 14: 2609–2617
Kanoh J, Sadaie M, Urano T, Ishikawa F (2005) Telomere binding
protein Taz1 establishes Swi6 heterochromatin independently of
RNAi at telomeres. Curr Biol 15: 1808–1819
Kloc A, Martienssen R (2008) RNAi, heterochromatin and the cell
cycle. Trends Genet 24: 511–517
LaBranche H, Dupuis S, Ben-David Y, Bani MR, Wellinger RJ,
Chabot B (1998) Telomere elongation by hnRNP A1 and a
derivative that interacts with telomeric repeats and telomerase.
Nat Genet 19: 199–202
Levy MZ, Allsopp RC, Futcher AB, Greider CW, Harley CB (1992)
Telomere end-replication problem and cell aging. J Mol Biol 225:
951–960
Luke B, Panza A, Redon S, Iglesias N, Li Z, Lingner J (2008) The
Rat1p 50 to 30 exonuclease degrades telomeric repeat-containing
RNA and promotes telomere elongation in Saccharomyces cerevi-
siae. Mol Cell 32: 465–477
Lundblad V, Szostak JW (1989) A mutant with a defect in telomere
elongation leads to senescence in yeast. Cell 57: 633–643
Marion RM, Strati K, Li H, Tejera A, Schoeftner S, Ortega S, Serrano
M, Blasco MA (2009) Telomeres acquire embryonic stem cell
characteristics in induced pluripotent stem cells. Cell Stem Cell 4:
141–154
McKay SJ, Cooke H (1992) hnRNPA2/B1 binds speciﬁcally to single
stranded vertebrate telomeric repeat TTAGGGn. Nucleic Acids Res
20: 6461–6464
Michishita E, McCord RA, Berber E, Kioi M, Padilla-Nash H, Damian
M, Cheung P, Kusumoto R, Kawahara TL, Barrett JC, Chang HY,
Bohr VA, Ried T, Gozani O, Chua KF (2008) SIRT6 is a histone H3
lysine 9 deacetylase that modulates telomeric chromatin. Nature
452: 492–496
Morcillo G, Barettino D, Carmona MJ, Carretero MT, Diez JL (1988)
Telomeric DNA sequences differentially activated by heat shock
in two Chironomus subspecies. Chromosoma 96: 139–144
Munoz P, Blanco R, de Carcer G, Schoeftner S, Benetti R, Flores JM,
Malumbres M, Blasco MA (2009) TRF1 controls telomere length
and mitotic ﬁdelity in epithelial homeostasis. Mol Cell Biol 29:
1608–1625
TERRA and telomeres
B Luke and J Lingner
&2009 European Molecular Biology Organization The EMBO Journal VOL 28 | NO 17 | 2009 2509Ng LJ, Cropley JE, Pickett HA, Reddel RR, Suter CM (2009)
Telomerase activity is associated with an increase in DNA methy-
lation at the proximal subtelomere and a reduction in telomeric
transcription. Nucleic Acids Res 37: 1152–1159
Ottaviani A, Gilson E, Magdinier F (2008) Telomeric position
effect: from the yeast paradigm to human pathologies?
Biochimie 90: 93–107
Palm W, de Lange T (2008) How shelterin protects mammalian
telomeres. Annu Rev Genet 42: 301–334
Pennock E, Buckley K, Lundblad V (2001) Cdc13 delivers separate
complexes to the telomere for end protection and replication.
Cell 104: 387–396
Redon S, Reichenbach P, Lingner J (2007) Protein RNA and protein
protein interactions mediate association of human EST1A/SMG6
with telomerase. Nucleic Acids Res 35: 7011–7022
Reichenbach P, Hoss M, Azzalin CM, Nabholz M, Bucher P, Lingner
J (2003) A human homolog of yeast Est1 associates with telomer-
ase and uncaps chromosome ends when overexpressed. Curr Biol
13: 568–574
Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA,
Goodnough LH, Helms JA, Farnham PJ, Segal E, Chang HY
(2007) Functional demarcation of active and silent chromatin
domains in human HOX loci by noncoding RNAs. Cell 129:
1311–1323
Rudenko G, Van der Ploeg LH (1989) Transcription of telomere
repeats in protozoa. EMBO J 8: 2633–2638
Sandell LL, Gottschling DE, Zakian VA (1994) Transcription
of a yeast telomere alleviates telomere position effect without
affecting chromosome stability. Proc Natl Acad Sci USA 91:
12061–12065
Schoeftner S, Blasco MA (2008) Developmentally regulated tran-
scription of mammalian telomeres by DNA-dependent RNA poly-
merase II. Nat Cell Biol 10: 228–236
Snow BE, Erdmann N, Cruickshank J, Goldman H, Gill RM,
Robinson MO, Harrington L (2003) Functional conservation of
the telomerase protein Est1p in humans. Curr Biol 13: 698–704
Solovei I, Gaginskaya ER, Macgregor HC (1994) The arrangement
and transcription of telomere DNA sequences at the
ends of lampbrush chromosomes of birds. Chromosome Res 2:
460–470
Ulaner GA, Giudice LC (1997) Developmental regulation of telomer-
ase activity in human fetal tissues during gestation. Mol Hum
Reprod 3: 769–773
Xu Y, Kimura T, Komiyama M (2008) Human telomere RNA and
DNA form an intermolecular G-quadruplex. Nucleic Acids Symp
Ser (Oxf) 52: 169–170
Yehezkel S, Segev Y, Viegas-Pequignot E, Skorecki K, Selig S (2008)
Hypomethylation of subtelomeric regions in ICF syndrome is
associated with abnormally short telomeres and enhanced
transcription from telomeric regions. Hum Mol Genet 17:
2776–2789
Zhang L, Ogawa Y, Ahn J, Namekawa S, Silva S, Lee JT (2009)
Telomeric RNAs mark sex chromosomes in stem cells. Genetics;
e-pub ahead of print 24 February 2009; doi: genetics. 109.103093
[pii]10.1534/genetics.109.103093
Zhang QS, Manche L, Xu RM, Krainer AR (2006) hnRNP A1
associates with telomere ends and stimulates telomerase activity.
RNA 12: 1116–1128
Zhao J, Sun BK, Erwin JA, Song JJ, Lee JT (2008) Polycomb proteins
targeted by a short repeat RNA to the mouse X chromosome.
Science 322: 750–756
EMBO
open
This is an open-access article distributed
under the terms of the Creative Commons
Attribution License, which permits distri-
bution, and reproduction in any medium, provided the original
author and source are credited. This license does not permit
commercial exploitation or the creation of derivative works
without speciﬁc permission.
TheEMBOJournalispublishedbyNaturePublishing
Group on behalf of European Molecular Biology
Organization. This article is licensed under a Creative Commons
Attribution-Noncommercial-No Derivative Works 3.0 Licence.
[http://creativecommons.org/licenses/by-nc-nd/3.0]
TERRA and telomeres
B Luke and J Lingner
The EMBO Journal VOL 28 | NO 17 | 2009 &2009 European Molecular Biology Organization 2510